However, this trend was reversed in other cancer types in which high WT1 associated with worse patient outcomes—colorectal cancer (relapse free survival: Fig S6C-D; GSE17536, GSE14333), lung cancer (overall survival: Fig S6E-F, GSE50081, GSE3141; relapse free survival: Fig S6G, GSE31210), ovarian cancer (overall survival: Fig S6H, GSE73614) and pancreatic cancer (overall survival: Fig S6I, TCGA-PAAD). Here, WT1 is linked to lung carcinoma.